Day One Biopharmaceuticals, Inc. - Common Stock (NQ:DAWN)

11.09 -0.93 (-7.78%)

Streaming Delayed Price Updated: 11:22 AM EST, Feb 25, 2026 Add to My Watchlist

Price and Volume

Volume	1,448,297
Open	10.89
Bid (Size)	11.07 (300)
Ask (Size)	11.10 (100)
Prev. Close	12.02
Today's Range	10.50 - 11.65
52wk Range	5.635 - 13.20
Shares Outstanding	73,572,633
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Day One Biopharmaceuticals Inc (NASDAQ:DAWN) Reports Q4 Revenue Beat but Wider Loss, Shares Dip ↗

February 24, 2026

Via Chartmill

Day One Bio (DAWN) Q4 2025 Earnings Transcript ↗

February 24, 2026

Day One Bio (DAWN) Q4 2025 Earnings Transcript

Via The Motley Fool

Performance

YTD	+25.3%	+25.3%
1 Month	-7.9%	-7.9%
3 Month	+17.6%	+17.6%
6 Month	+48.6%	+48.6%
1 Year	-9.0%	-9.0%

More News

Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance

February 24, 2026

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026

February 10, 2026

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

AIGH Capital Dumps 2.6 Million Lumen Technologies Shares In $15.6 Million Exit ↗

February 03, 2026

Via The Motley Fool

Keep an eye on the top gainers and losers in Monday's session. ↗

January 12, 2026

Via Chartmill

Gapping stocks in Monday's session ↗

January 12, 2026

Via Chartmill

Top movers in Monday's pre-market session ↗

January 12, 2026

Via Chartmill

Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance

January 11, 2026

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Curious about the stocks that are showing activity after the closing bell on Friday? ↗

January 09, 2026

Via Chartmill

Day One Completes Acquisition of Mersana Therapeutics

January 06, 2026

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 16, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

November 24, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 18, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Mersana Therapeutics Stock Explodes Over 200% To Notch Best Day Ever As $285M Buyout Trumps Analyst Downgrades: Retail Cheers ‘Very Good Bargain’ ↗

November 14, 2025

Via Stocktwits

Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout ↗

November 13, 2025

Via Benzinga

Mersana Catapults 200% On Day One Bio's Surprise Buyout ↗

November 13, 2025

Via Investor's Business Daily

MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal ↗

November 13, 2025

Via Stocktwits

Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases

November 13, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting

November 10, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Keep an eye on the top gainers and losers in Wednesday's session. ↗

November 05, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 05, 2025

Via Benzinga

Day One Reports Third Quarter 2025 Financial Results and Corporate Progress

November 04, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025

October 21, 2025

From Day One Biopharmaceuticals, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Day One Biopharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Day One Biopharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Day One Biopharmaceuticals, Inc. - Common Stock trade on?

Day One Biopharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Day One Biopharmaceuticals, Inc. - Common Stock?

The ticker symbol for Day One Biopharmaceuticals, Inc. - Common Stock is DAWN on the Nasdaq Stock Market

What is the current price of Day One Biopharmaceuticals, Inc. - Common Stock?

The current price of Day One Biopharmaceuticals, Inc. - Common Stock is 11.09

When was Day One Biopharmaceuticals, Inc. - Common Stock last traded?

The last trade of Day One Biopharmaceuticals, Inc. - Common Stock was at 02/25/26 11:22 AM ET

What is the market capitalization of Day One Biopharmaceuticals, Inc. - Common Stock?

The market capitalization of Day One Biopharmaceuticals, Inc. - Common Stock is 815.55M

How many shares of Day One Biopharmaceuticals, Inc. - Common Stock are outstanding?

Day One Biopharmaceuticals, Inc. - Common Stock has 816M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.